IMARC Group’s latest research report, titled “Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global companion animal health market reached a value of US$ 21.18 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 36.19 Billion by 2027, exhibiting a CAGR of 8.80% during 2022-2027.Companion animal health represents the regular monitoring of the health of animals to detect diseases and other conditions that can put their lives in danger if left untreated. It involves the development of therapeutic vaccines, anti-neoplastic drugs, monoclonal antibody therapies, genomic tests, digital technologies, etc. Animals, such as dogs, cats, equines, etc., are taken for health diagnostics. Companion animal health finds widespread applications in veterinary hospitals, clinics, in-house testing, point-of-care testing, etc.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/companion-animal-health-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by animal type, product and end user.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Companion Animal Health Market
- Strategies of major players and product offerings
Animal aging leads to a rise in the risk of obesity, osteoarthritis, tumors, cardiovascular diseases (CVDs), diabetes mellitus, hepatic, renal diseases, etc., which is primarily driving the companion animal health market. Besides this, the rising awareness towards the One Health (OH) approach initiative, which recognizes that public health is connected with animal health and is supported by the World Health Organization (WHO) and the American Veterinary Medical Association (AVMA), is further augmenting the market growth. Apart from this, the elevating utilization of animal-assisted therapy in various areas of human health care and the growing population of traditional companion animals, including dogs and cats, are also catalyzing the global market.
Moreover, the inflating number of pet parents across counties who are aware of the overall health and well-being of companion animals is acting as another significant growth-inducing factor. Furthermore, the increasing prevalence of zoonotic diseases across the globe is expected to bolster the companion animal health market in the coming years.
Key Players Included in Global Companion Animal Health Market Research Report:
- Agrolabo S.p.A.
- Boehringer Ingelheim
- Ceva Santé Animale
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- IDEXX Laboratories Inc.
- Indian Immunologicals Limited (National Dairy Development Board)
- Merck & Co. Inc.
- Norbrook Laboratories
- Vetoquinol SA
- Virbac and Zoetis Inc.
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
- Feed Additives
- Point-of-care Testing/In-house Testing
- Veterinary Hospitals and Clinics
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Companion Animal Health Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Companion Animal Health Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Also Read: https://answerques.com/